The therapeutic potential of Sirt2 inhibition was also demonstrated recently in a murine model of TB, where the Sirt2 inhibitor AGK2 restricted intracellular growth of both drug-susceptible and resistant strains of Mtb and enhanced the efficacy of INH39. The gene discussed is SIRT2; the disease is tuberculosis.